Navigation Links
Gates Foundation and Mayo Clinic Experts to Address Vaccine Research in the 21st Century
Date:10/23/2013

Bethesda, MD (PRWEB) October 23, 2013

Dr. Penny Heaton, Director of Vaccine Development, Global Health Program at the Bill and Melinda Gates Foundation and Dr. Gregory A. Poland, Director, Mayo Vaccine Research Group at the Mayo Clinic will present keynote addresses on global vaccine research and development in the 21st century at the 17th Annual Conference on Vaccine Research, sponsored by the National Foundation for Infectious Diseases (NFID). The conference is scheduled for April 28-30, 2014 in Bethesda, MD.

Vaccines are responsible for the control of many infectious diseases that were once common in this country and around the world, including polio, measles, diphtheria, pertussis (whooping cough), rubella (German measles), mumps, tetanus, and Haemophilus influenzae type b (Hib). Vaccines also eradicated smallpox, one of the most devastating diseases in history, and have prevented countless cases of infectious diseases, saving millions of lives.

According to the Bill and Melinda Gates Foundation, global immunization coverage has never been higher. More than 100 million children are immunized each year, saving an estimated 2.5 million lives. The Global Vaccine Action Plan (GVAP) focuses on making vaccines accessible in the developing world, and supporting vaccine research and development. “All children and their parents should have the same opportunity to receive life-saving vaccines regardless of where they may live,” said Dr. Heaton.

Vaccines of the future may be even more effective. According to Dr. Poland, “vaccines, like drugs and medical procedures, are increasingly amenable to individualization or personalization. As a result of new technologies, 21st century vaccinology will increasingly see the abandonment of a ‘one size fits all’ approach to vaccine dosing and delivery.” Dr. Poland’s work is leading to new understandings of how vaccines stimulate immune responses and which genetic and other factors may affect vaccine response.

NFID’s Annual Conference on Vaccine Research provides high-quality, current reports of scientific progress and best practices in the field of vaccinology, and brings together the diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. By drawing upon an international audience of scientists and researchers, healthcare professionals and trainees, veterinarians, vaccine manufacturers, and public health officials, the conference is designed to encourage the exchange of ideas across a broad range of disciplines. Topics to be presented include:

  •     Future Trends in Vaccine Research
  •     Current Challenges in Immunization Policy
  •     Vaccines for the Developing World
  •     Regulatory Challenges of Evaluating and Approving Adjuvanted Vaccines
  •     Innovations in Influenza Vaccines
  •     Immunology and Vaccine Discovery

About the National Foundation for Infectious Diseases

Celebrating its 40th anniversary, the National Foundation for Infectious Diseases (NFID) is a non-profit, tax-exempt 501(c)(3) organization founded in 1973 and dedicated to educating the public and healthcare professionals about the causes, treatment, and prevention of infectious diseases. Visit http://www.nfid.org for more information.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11257277.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Gadgets Made Simple Investigates The Technology Behind AMG Services Bolting Solutions
2. Zamansky LLC Investigates C.R. Bard Inc. On Behalf Of Long-Term Shareholders Over Allegations Related to Vaginal-Mesh Implants
3. Women's Strike Force Announces First Fund Distribution to Virginia House of Delegates Candidates for November Race
4. Allegedly, Fraudulent Marketers Are Joining with Banks to Scam the Elderly; Parker Waichman LLP Investigates a Potential Class Action Lawsuit
5. Sometimes, the Most Evil Things Come from the Most Holy… 3 Gates of the Dead by Jonathan Ryan to be Published by Premier Digital Publishing on October 15, 2013
6. EORTC led intergroup trial investigates Imatinib failure-free survival in patients with GIST
7. Queens University receives Bill and Melinda Gates Foundation grants
8. Gates Fellowship addresses parasite infection in developing world
9. Local San Antonio Research Clinic Investigates New Osteoarthritis Treatments
10. Zamansky & Associates LLC Investigates Chemed Corporation For Possible Securities Law Violations And Breaches Of Fiduciary Duties To Shareholders
11. How is a Latex Mattress Created? The Mattress Geek Investigates in Latest Article
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... NY (PRWEB) , ... December 09, 2016 , ... ... and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... and the District of Columbia as an education tool in the war against teen ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... Pierre Hotel in New York, NY, on December 3rd, to benefit Holy Name ... attended the annual event, which raised over $1 million - the largest event ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Quality Insights beginning January 1, 2017. The name change aligns the entire ... measuring and improving health care quality. , “We are very proud of the ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... DIEGO , Dec. 9, 2016 aTyr Pharma, Inc. ... discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, ... at the upcoming BMO Prescriptions for Success Healthcare Conference at the ... on Wednesday, December 14, 2016, at 4:20 p.m. ET. ... ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences Ltd. ... biopharmaceutical company focused on the treatment of dementia, ... from a Phase 2b trial evaluating treatment with ... compared with donepezil plus placebo in people with ... addition of intepirdine to treatment was associated with ...
(Date:12/8/2016)... , Dec. 8, 2016 Australia Glaucoma ... GlobalData,s new report, "Australia Glaucoma Surgery Devices ... on the Australia Glaucoma Surgery Devices market. The ... volume (in units) and average prices (USD) within ... report also provides company shares and distribution shares ...
Breaking Medicine Technology: